ASO Video Abstract: Neoadjuvant Chemo-Immunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable NSCLC

Ann Surg Oncol. 2023 Nov;30(12):7599. doi: 10.1245/s10434-023-14163-2.
No abstract available